CLDI has the potentialThe price and the volume is a confirmation. The only issue is the previous highs. Has to clear the resistance. So grabbed some in anticipation
Next report date
Report period
Q1 2024
EPS estimate
−0.28USD
Revenue estimate
—
−1.0304USD
−29.22 MUSD
20.34 M
About Calidi Biotherapeutics, Inc.
Sector
Industry
CEO
Allan J. Camaisa
Website
Headquarters
San Diego
Employees (FY)
41
Founded
2014
FIGI
BBG012QFCL84
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CLDI is 0.2080 USD — it has increased by 29.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Calidi Biotherapeutics, Inc. stocks are traded under the ticker CLDI.
Calidi Biotherapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CLDI stock is 100.19% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is Calidi Biotherapeutics, Inc. there?
CLDI earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.17 USD resulting in a 17.65% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Calidi Biotherapeutics, Inc. earnings.
Yes, you can track Calidi Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CLDI stock has risen by 23.59% compared to the previous week, the month change is a 65.91% fall, over the last year Calidi Biotherapeutics, Inc. has showed a 97.97% decrease.
CLDI net income for the last quarter is −8.23 M USD, while the quarter before that showed −2.02 M USD of net income which accounts for −306.57% change. Track more Calidi Biotherapeutics, Inc. financial stats to get the full picture.
Today Calidi Biotherapeutics, Inc. has the market capitalization of 5.74 M, it has decreased by 24.24% over the last week.
No, CLDI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLDI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Calidi Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 41.00 employees. See our rating of the largest employees — is Calidi Biotherapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Calidi Biotherapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Calidi Biotherapeutics, Inc. stock shows the sell signal. See more of Calidi Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Calidi Biotherapeutics, Inc. future price: according to them, CLDI price has a max estimate of 4.50 USD and a min estimate of 2.00 USD. Read a more detailed Calidi Biotherapeutics, Inc. forecast: see what analysts think of Calidi Biotherapeutics, Inc. and suggest that you do with its stocks.